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2Abstract
Immune reactions against microorganisms play an important pathogenic role in
Adamantiades-Behçet’s disease (ABD). We had previously obtained Streptococcus
sanguinis (strain BD113-20) isolated from the oral cavity of patients with ABD. To
investigate the pathogenesis of this isolate, we examined neutrophil reactions and level5
of cytokine production by lymphocytes after stimulation with the strain. The reactions
of neutrophils were examined by chemiluminescence assay using whole blood. The
amounts of interferon gamma (IFN-g) and interleukin (IL)-4, IL-8, IL-10, and IL-12
produced by peripheral blood mononuclear cells (PBMCs) were measured by ELISA.
Strain BD113-20 activated neutrophils from patients with ABD and healthy volunteers,10
and, in addition it increased IFN-g production by lymphocytes. Lymphocyte from the
patients with ABD showed a dominant T helper 1 (Th-1) immune response. Results
indicated that both bacterial stimulation and host hypersensitivity might be involved in
the symptoms and pathogenesis of ABD.
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31. Introduction
Adamantiades-Behçet’s disease (ABD) is a multi-system disorder that presents
with recurrent oral and genital ulceration as well as uveitis, leading sometimes to
blindness. Although the etiology and pathogenesis of this disease remain obscure,
different bacteria and viruses have been suggested as causative factors. Several5
investigators have reported that streptococcal infection is related to the onset of ABD.
Patients with ABD have shown significantly higher incidences of tonsillitis and dental
caries, probably due to streptococci, and the lymphocytes obtained from such patients
were sensitive to streptococcal antigens [1, 2]. Additionally, patients with ABD showed
hypersensitivity in skin tests to streptococcal antigens [3]. We have previously shown10
that the proportion of Streptococcus sanguinis (strain BD113-20 isolated from a patient
with ABD) in the oral flora of patients with ABD was significantly higher than in
controls [4], and the serum anti-BD113-20 titers of the patients were also higher than
titers to standard strains [5]. In another study, patients’ sera did not neutralize bacterial
IgA protease purified from BD113-20, demonstrating that humoral immunity against15
oral streptococci in patients with ABD was not sufficient to exclude the oral bacteria [6].
Taken together, these results suggest that both host immunity and oral bacteria are
involved in the pathogenesis of ABD.
In this study, we demonstrate the neutrophil and lymphocyte reactions against S.
sanguinis BD113-20 isolated from patients with ABD. Neutrophil reactions were20
examined by chemiluminescence (CL) assay using whole blood stimulated with
streptococcal antigens and zymozan. Peripheral blood mononuclear cells (PBMCs) were
also stimulated with streptococcal antigens, and their T helper 1- and 2-associated
cytokines were investigated.
42. Materials and Methods
2.1. Patients
Nineteen patients with ABD (8 men and 11 women; aged 32 to 79, mean 55.8
years), diagnosed according to the international study group criteria were studied.
Historical information of 19 patients with ABD is shown in Table 1. Clinical5
information at the time of drawing blood is also shown in Table 2.  Twenty-one healthy
volunteers (11 men and 10 women; aged 21 to 41, mean 30.8 years) were used as
controls. Heparinized blood was obtained of which a portion was used for neutrophil
examination within 2 hours. The remaining heparinized peripheral blood was layered on
a Ficoll-Paque density gradient solution and centrifuged (3000xg, 30 min). The upper10
layer, containing plasma and platelets, was removed, and the buffy coat, the rich
fraction in peripheral mononuclear cells (PBMCs) collected. The PBMCs were washed
twice with phosphate buffered saline (PBS, pH 7.2) and cultured in RPMI1640 medium
containing 10% fetal calf serum (FCS).
2.2. Bacterial strains15
Streptococcus sanguinis strain BD113-20, isolated from the mouths of patients
with ABD, was employed. Streptococcus pyogenes  (WHO-T type 12), Streptococcus
salivarius (ATCC 7073), and Streptococcus sanguinis (ATCC 10556) were also used as
control strains. All strains were cultured in Todd-Hewitt broth (Difco, Detroit, MI) at
37C for 18 hr. The cells were harvested by centrifugation (6,000xg, 20 min, 4 C) and20
washed three times with 10 mM PBS. The whole cells were disrupted with a Branson
cell homogenizer (Branson model 250 sonifier, Branson Ultrasonices, Danbury, CN),
and the unbroken cells were removed by centrifugation (6,000xg, 20 min, 4 C). The
supernatants were again centrifuged at high speed (20,000xg, 30 min, 4 C), and the
5resulting supernatants were designated as the 20S antigen.
2.3. Chemiluminescence (CL) assay
Neutrophil activity was measured using a CL assay. Heparinized blood (100 ml)
was suspended in 400 ml of Hanks solution with 20 mM HEPES and 10mM CaCl2 (pH
7.4, HEPES-Hanks). The blood in the HEPES-Hanks solution was added to 10 ml of5
luminol solution (2 mg ml-1), and then stimulated with 50 ml of streptococcal antigens
(10mg ml-1) or non-opsonized zymozan (5 mg ml-1). The antigens’ CL was immediately
measured with a luminometer (Biolumat LB9505, Berthord, Germany).
2.4. Measuring Cytokine production levels
PBMCs (1x106 cells ml-1) were washed three times in RPMI 1640 by10
centrifugation. Aliquot of 500 ml of cell suspentions were cultured in a 48 well plate
stimulated with the bacterial antigen of S. sanguinis (ATCC10556), BD113-20 (10 mg
ml-1), or concanavalin A (5 mg ml-1: conA). Culture supernatants were collected at one
week, and stored at –80 C. IFN-g, IL-4, IL-8, IL-10 and IL-12 levels were measured
using an ELISA kit (Biosource, Camarillo,CA) according to the manufacturer’s15
instructions.
2.5. Statistical analysis
Results were expressed as means + standard error (SE). Data were compared
using a Student’s t-test, and statistical differences were considered significant if p
values were <0.05.20
63. Results
3.1. Neutrophil activation
BD113-20 was isolated from a patient with ABD and used to assess stimulation
of neutrophils in a CL assay. The stimulation by BD113-20 was significantly greater
(p<0.05) in both ABD and control subjects than was observed for other Streptococcus5
antigens or by zymosan (Fig. 1). CL in patients with ABD was also activated by the S.
sanguinis type-strain (ATCC10556). However, on stimulation with S. pyogenes, CL did
not differ between patients and controls. In the healthy volunteers, stimulation with S.
salivarius induced strong CL activity. These results indicate that in the ability to activate
neutrophils, BD113-20 may differ from other oral streptococcci.10
Stimulation with strain BD113-20 induced high levels of IL-8 production by
PBMCs in both the patients (867+55 ng ml-1) and the controls (599+82 ng ml-1) (Fig. 2).
Also, the level of production was significantly (p=0.027) higher in the patients with
ABD than controls. The S. sanguinis type-strain did not induce IL-8 production either in
patients with ABD or in controls. Infection with BD113-20 in patients with ABD may15
enhance neutrophil activation.
3.2. Levels of Th-1/2-associating cytokines
Stimulation with BD113-20 induced high levels of IFN-g production from
PBMCs of patients with ABD (2254+238 pg ml-1) and controls (2301+399 pg ml-1) (Fig.
3). The type-strain of S. sanguinis (ATCC10556) induced IFN-g (1075+249 pg ml-1)20
production by PBMCs from the patients with ABD, however little IFN-g (125+69 pg ml-
1) was produced by lymphocytes from controls.
The type strain of S. sanguinis (ATCC10556) and BD113-20 induced a high
level of production of IL-12 (S. sanguinis (ATCC10556) stimulation; 1975+410 pg ml-1,
7BD113-20 stimulation; 2540+430 pg ml-1) by PBMCs of the patients (Fig. 4). On
stimulation with any antigen, IL-12 production from PBMCs from patients with ABD
was significantly increased compared to that by PBMCs of controls.
Levels of Th-2 associated cytokines (IL-4 and IL-10) were low. Specifically,
little IL-4 was detected in PBMCs of patients with ABD or controls (data not shown).5
Stimulation with the S. sanguinis type-strain (ATCC10556) induced significant IL-10
production (130+34 pg ml-1) from PBMCs in patients with ABD (Fig. 5), while conA
stimulation did not enhance IL-10 secretion from PBMCs. On the other hand, the
healthy volunteers’ PBMCs produced IL-10 following stimulation with BD113-20
(95+33 pg ml-1) and conA (72+33 pg ml-1). For PBMCs from controls, the IL-10 level,10
without stimulation, was below the detection limit. These results indicate that patients
with ABD have a Th-1 dominant immunity, and infection with BD113-20 might
enhance the Th-1 immune reaction.
3.3 Disease activity
The mean age when first symptoms arose in the patients was 36.7 years old,15
and 12 of 19 patients (63.5%) had developed aphthous stomatitis as a first symptom
(Table 1). Disease activity of each patient is shown in Table 2. The CL and production
of cytokines were not associated with active or inactive symptoms (Data not shown).
84. Discussion
Immunopathogenic mechanisms are closely associated with the etiology of
ABD. Both microbial antigens and host immune responses may contribute to this multi-
systemic disorder, presenting various symptoms [7]. We have previously reported that S.
sanguinis BD113-20 isolated from a patient with ABD, may be an important bacterium5
stimulating host immunity [4, 5, 6]. In this study, neutrophil reactions and T helper
(Th-) 1 or 2 immunity-associated lymphokines were examined using soluble antigens of
the strain.
Neutrophil activation is involved in the pathogenesis of ABD, as evidenced by
the lesions that are characteristic of neutrophil infiltration of the pustular folliculitis and10
hypopyon [8]. It has been reported that neutrophil reactions were associated with some
viridans Streptococcus or group B Streptococcus [9, 10]. In this study, we found that
BD113-20 significantly enhanced CL activity in neutrophils, and may be different from
other oral streptococci. In addition, as a host factor, IL-8 was produced at high levels by
lymphocytes of patients with ABD than healthy volunteers. High levels of expression of15
IL-8 mRNA in patients with ABD have also been reported [11, 12], and IL-8 seems to
be a reliable marker for disease activity [13]. Neutrophil activation may be promoted by
the IL-8 released from lymphocytes and/or endothelial cells of patients with ABD.
Streptococcus exists as oral flora in patients with ABD, whose symptoms may often be
caused by dental treatment or aphthous stomatitis.20
Throughout life, viridans streptococci comprise a large proportion of the
commensal microbiota in the oral cavity and pharynx [14], and different species of
viridans streptococci are known to colonize distinct habitats within the mouth [15].
Uncommon streptococcus strains, such as strain BD113-20, were increased in oral flora
9of patients with ABD [16], and were not eradicated by IgA mucosal immunity [6]. Both
persistent infection by the neutrophil-activating Streptococcus and the lymphocyte
responses are presumed to play an important role in the symptoms of ABD.
Long-term bacterial stimulation will induce adaptive immunity in patients with
ABD. T-cell activation, both in the peripheral blood and in tissue specimens, occurs in5
ABD. The CD4-positive cells are divided into Th-1 and Th-2 cells. The differential
effects of Th-1 and Th-2 populations are mediated through their characteristic cytokines.
IL-12 is produced by macrophages and is a potent inducer of IFN-g production by Th-1
cells and natural killer cells. IL-12, in concert with the presentation of antigens by
dendritic APC, is believed to promote the induction of CD4 positive TDTH cells and TCTL10
cells, thus directing the immune response to cell-mediated immunity. IL-12 production
was significantly increased with or without stimulation in lymphocytes from patients
with ABD. Numbers of IFN-g and IL-2-producing T cells were increased in peripheral
blood from patients with ABD, and were correlated with disease activity [16, 17]. High-
level production of IFN-g was also induced by BD113-20. Bacterial stimulation may15
enhance Th-1 cell-mediated immunity in patients with ABD, resulting in the progression
of chronic inflammation. We are now studying mechanisms by which production of
IFN-g and IL-12 is induced by BD113-20.
IL-10 is secreted from Th-2 cells, and it down-regulates Th-1 immunity and
inflammation. IL-10 production in the patients and controls was at a low level and20
variable. We recognized no clear tendency in IL-10 production. IL-4 is also produced by
Th-2 cells, however its level was below the detection limit in this study. Serum IL-4, IL-
10, and IL-13 levels in patients with ABD were detectable but the pathogenic roles of
Th-2-associating cytokines are still not clear [18, 19]. Our study indicates that the Th-2
10
humoral immunity against oral Streptococcus may be diverse in individuals, and it may
not be effective for a case of stimulation with streptococcal antigens. On the other hand,
autoantibodies against heat shock proteins (65kDa and ab-crystallin), which may be
induced by bacterial stimulation, and endothelial cells have been detected in patients
with ABD [20,21,22]. Although humoral immunity may play an important pathogenic5
role in ABD, any association with bacterial stimulation and the induction of
autoantibodies is still obscure.
Some papers indicated that cytokine profiles in serum and/or production from
PBMC are different in disease activity [18, 23]. PBMC from patients with ABD
produced higher levels IL-4, IL-10, and IL-13, and the additions of IFN-g to the anti-10
CD3 stimulated PBMC changed Th-1/Th-2 pattern with enhanced IL-12 and decreased
IL-4 and IL-10 production [19]. Number of cell spontaneously secreting IFN-g, IL-12,
and TNF-a were increased in patients with active ABD [23]. In contrast, our result
indicated that cytokine pattern was not different in the inactive and active patients.
Some researchers in the Japanese Behçet’s disease committee reported that PBMCs15
from patients were already activated in vivo by some antigen. They reported that
lymphocytes had been produced IL-8 or TNF for 1-2 days without stimuli (personal
communication). Other papers also indicated that lymphocytes from patients with ABD
were activated by some antigens in vivo. To eliminate the influence of original stimuli in
the patients, PBMCs were washed three times and cultured for one week in this study.20
The PBMC from both inactive and active patients was produced high IL-8 and Th-1
associated cytokines. The immunological future against antigen stimulations may be
important for host factor of induction of ABD.
In conclusion, S. sanguinis (BD113-20) isolated from a patient with ABD had
11
the capacity to stimulate activated neutrophils. Lymphocytes from patients with ABD
showed high levels of production of IL-8, IFN-g and IL-12 due to the neutrophil-
activating bacteria. This study suggests that both bacterial stimulation and host
hypersensitivity are involved in the symptoms and pathogenesis of ABD.
5
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Table 1. Historical information of patients with ABD
Age when
Patient
number Age Sex
first
symptoms
appeared First symptoms
1 32 m 20 oral ulcer
2 54 m 49 oral ulcer, ENa, arthritis
3 49 f 32 oral ulcer, uveitis
4 32 m 30 uveitis
5 43 f 23 uveitis
6 73 f 60 uveitis
7 79 f 68 EN
8 71 m 43 uveitis
9 68 m 43 oral ulcer, papula
10 52 m 32 oral ulcer
11 45 f 34 oral ulcer, EN, genital ulcer
12 45 m 34 oral ulcer, uveitis
13 64 f 37 uveitis
14 62 f 35 uveitis, EN
15 61 m 23 oral ulcer
16 49 f 33 oral ulcer
17 49 f 33 oral ulcer
18 62 f 37 oral ulcer
19 56 f 32 oral ulcer
aEN; erythema nodosum
17
 
Table 2. Clinical data of patients with ABD.
Patient
Number Present symptoms except for uveitis Treatment ESRb CRP ASO Activity
1 oral ulcer colchicine 16 + - oral ulcer, uveitis
2 oral ulcer, ENa, arthritis, genital ulcer steroid (instillation), colchicine - - NTc EN
3 oral ulcer, EN, arthritis steroid, cyclosporine, colchicine - - - -
4 oral ulcer, EN, arthritis, epididymitis steroid, colchicine - - NT uveitis
5 oral ulcer, erythema, steroid, colchicine - - - oral ulcer, uveitis
6 oral ulcer, arthritis steroid, colchicine - - NT oral ulcer, uveitis
7 oral ulcer, EN, arthritis steroid, colchicine - - NT oral ulcer, uveitis
8 oral ulcer, genital ulcer steroid (instillation), colchicine - + NT oral ulcer, EN
9 oral ulcer, EN, arthritis, genital ulcer colchicine - - NT oral ulcer
10 oral ulcer, genital ulcer (-) - - NT -
11 oral ulcer, EN, genital ulcer cyclosporine, colchicine - + NT uveitis
12 oral ulcer, EN cyclosporine, colchicine 41 + NT uveitis
13 (-) steroid (active symptoms) - + NT -
14 EN steroid (active symptoms) - + NT -
15 oral ulcer colchicine - - NT -
16 oral ulcer colchicine 16 - NT -
17 oral ulcer, EN steroid, colchicine - - - -
18 oral ulcer, genital ulcer steroid (instillation), colchicine - - NT -
19 oral ulcer, EN colchicine 28 - - EN. uveitis
aEN; erythema nodosum, bESR; erythrocyte sedimentation rate (mm/hr), cNT=not tested
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Figure legends
Fig. 1. Chemiluminescence assay with various antigens
Whole blood obtained from patients with ABD (n=19) and healthy volunteers (n=21)
was stimulated with zymozan and Streptococcus antigens. Asterisks (*) indicate
significantly (p<0.05) lower values than in both the patients and controls stimulated5
with antigen of strain BD113-20 (a strain isolated from s patient with ABD).
Fig. 2. IL-8 production by peripheral lymphocytes
Lymphocytes from the patients (ABD; n=19) and controls (n=21) were stimulated with
S. sanguinis (ATCC10556 or strain BD113-20) or conA. Asterisks (*) with bars indicate
significant differences (p<0.05).10
Fig. 3. IFN-g production by peripheral lymphocytes
Lymphocytes from the patients (ABD; n=19) and healthy controls (n=21) were
stimulated with S. sanguinis (ATCC10556 or strain BD113-20) or conA. Asterisks (*)
with bars indicate significant differences (p<0.05).
Figure 4. IL-12 production from peripheral lymphocytes15
Lymphocytes from the patients (ABD; n=19) and controls (n=21) were stimulated with
S. sanguinis (ATCC10556 or strain BD113-20) or conA. Asterisks (*) with bars indicate
significant differences (p<0.05).
Fig. 5. IL-10 production by peripheral lymphocytes
Lymphocytes from the patients (ABD; n=19) and controls (n=21) were stimulated with20
S. sanguinis (ATCC10556 or strain BD113-20) or conA. Asterisks (*) with bars indicate
significant differences (p<0.05).
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